Please assess the completion status of the following clinical trial:

Trial Title: Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Positive Sinerem®-enhanced MRI of carotid plaque confirmed by a consultant neuroradiologist~* Must either be statin naive or have been on a stable dose of a statin(Permitted statins and total daily dose are as follows: atorvastatin =10mg, simvastatin =40mg, pravastatin =40mg, fluvastatin =80mg, rosuvastatin =10mg for =4 weeks prior to screening, with no evidence of statin intolerability.)~Exclusion criteria:~* Require continued use of non-statin lipid modifying therapies or therapy with any other lipid regulating medications~* History of statin intolerance~* History of chronic viral hepatitis or other liver dysfunction~* Renal impairment with serum creatinine \>2.5 mg/dl (\>221 mol/L)~* History of myopathy or inflammatory muscle disease, or 3 times more than the upper limit of normal levels of total creatinine kinase in serum~* Doppler assessment of less than 40% stenosis during screening assessment~* Allergy to dextran and iron salts~* Contraindication to MRI scanning~* Planned carotid surgery or endovascular intervention earlier than 10 weeks within the study period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).